Cargando…

Results of Second-Look Laparotomy in Advanced Ovarian Cancer: One Single Center Experience

Objective. The goal of the study was to analyse the results of 85 cases of second-look laparotomy (SLL) and explore the influence of this procedure on survival. Patients and Methods. We reviewed retrospectively 85 cases of SLL collected and treated in our institute between 1994 and 2003. Results. Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Damak, Tarak, Chargui, Riadh, Ben Hassouna, Jamel, Hechiche, Monia, Rahal, Khaled
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479993/
https://www.ncbi.nlm.nih.gov/pubmed/23119177
http://dx.doi.org/10.5402/2012/849518
_version_ 1782247492659707904
author Damak, Tarak
Chargui, Riadh
Ben Hassouna, Jamel
Hechiche, Monia
Rahal, Khaled
author_facet Damak, Tarak
Chargui, Riadh
Ben Hassouna, Jamel
Hechiche, Monia
Rahal, Khaled
author_sort Damak, Tarak
collection PubMed
description Objective. The goal of the study was to analyse the results of 85 cases of second-look laparotomy (SLL) and explore the influence of this procedure on survival. Patients and Methods. We reviewed retrospectively 85 cases of SLL collected and treated in our institute between 1994 and 2003. Results. Complete pathologic response (CPR) was 25.8%, microscopic disease (Rmicro) was 38.8%, and macroscopic disease (Rmacro) was 35.4%. In patients with negative SLL results, disease recurrence was diagnosed in 41%. The 3- and 5-year overall survival rates for the entire population were 91% and 87%, respectively. The 3- and 5-year disease-free survivals were, respectively, 76.3% and 58.5% in negative SLL versus 55.7% and 16% in positive SLL. The difference between the group of patients with complete response (76%) and the patients with residual microscopic disease (72%) was not significant. The tumoral residuum after initial surgery was the only prognostic factor influencing significantly the disease-free survival. On Cox regression model analysis, only initial tumoral residuum (P = 0.04) and tumoral residuum after SLL (P = 0.02) were independent prognostic factors for survival. Conclusions. The most important advantage of SLL is the early detection of recurrence and thus the early administration of consolidation treatment resulting in a better prognosis.
format Online
Article
Text
id pubmed-3479993
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher International Scholarly Research Network
record_format MEDLINE/PubMed
spelling pubmed-34799932012-11-01 Results of Second-Look Laparotomy in Advanced Ovarian Cancer: One Single Center Experience Damak, Tarak Chargui, Riadh Ben Hassouna, Jamel Hechiche, Monia Rahal, Khaled ISRN Obstet Gynecol Research Article Objective. The goal of the study was to analyse the results of 85 cases of second-look laparotomy (SLL) and explore the influence of this procedure on survival. Patients and Methods. We reviewed retrospectively 85 cases of SLL collected and treated in our institute between 1994 and 2003. Results. Complete pathologic response (CPR) was 25.8%, microscopic disease (Rmicro) was 38.8%, and macroscopic disease (Rmacro) was 35.4%. In patients with negative SLL results, disease recurrence was diagnosed in 41%. The 3- and 5-year overall survival rates for the entire population were 91% and 87%, respectively. The 3- and 5-year disease-free survivals were, respectively, 76.3% and 58.5% in negative SLL versus 55.7% and 16% in positive SLL. The difference between the group of patients with complete response (76%) and the patients with residual microscopic disease (72%) was not significant. The tumoral residuum after initial surgery was the only prognostic factor influencing significantly the disease-free survival. On Cox regression model analysis, only initial tumoral residuum (P = 0.04) and tumoral residuum after SLL (P = 0.02) were independent prognostic factors for survival. Conclusions. The most important advantage of SLL is the early detection of recurrence and thus the early administration of consolidation treatment resulting in a better prognosis. International Scholarly Research Network 2012-10-16 /pmc/articles/PMC3479993/ /pubmed/23119177 http://dx.doi.org/10.5402/2012/849518 Text en Copyright © 2012 Tarak Damak et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Damak, Tarak
Chargui, Riadh
Ben Hassouna, Jamel
Hechiche, Monia
Rahal, Khaled
Results of Second-Look Laparotomy in Advanced Ovarian Cancer: One Single Center Experience
title Results of Second-Look Laparotomy in Advanced Ovarian Cancer: One Single Center Experience
title_full Results of Second-Look Laparotomy in Advanced Ovarian Cancer: One Single Center Experience
title_fullStr Results of Second-Look Laparotomy in Advanced Ovarian Cancer: One Single Center Experience
title_full_unstemmed Results of Second-Look Laparotomy in Advanced Ovarian Cancer: One Single Center Experience
title_short Results of Second-Look Laparotomy in Advanced Ovarian Cancer: One Single Center Experience
title_sort results of second-look laparotomy in advanced ovarian cancer: one single center experience
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479993/
https://www.ncbi.nlm.nih.gov/pubmed/23119177
http://dx.doi.org/10.5402/2012/849518
work_keys_str_mv AT damaktarak resultsofsecondlooklaparotomyinadvancedovariancanceronesinglecenterexperience
AT charguiriadh resultsofsecondlooklaparotomyinadvancedovariancanceronesinglecenterexperience
AT benhassounajamel resultsofsecondlooklaparotomyinadvancedovariancanceronesinglecenterexperience
AT hechichemonia resultsofsecondlooklaparotomyinadvancedovariancanceronesinglecenterexperience
AT rahalkhaled resultsofsecondlooklaparotomyinadvancedovariancanceronesinglecenterexperience